- Poster presentation
- Open Access
Can serum amyloid a level be used to support the Familial Mediterranean Fever diagnosis?
© Ozturk and Ekinci; licensee BioMed Central Ltd. 2014
- Published: 17 September 2014
- White Blood Cell
- Erythrocyte Sedimentation Rate
- Positive Predictive Value
- Negative Predictive Value
Familial Mediterranean Fever (FMF) is a periodic fever syndrome characterized by recurrent episodes of fever and serosal inflammation .The diagnosis is still based on clinical criteria. No laboratory test is diagnostic of FMF. During the attacks increased C reactive protein (CRP), serum amyloid A (SAA), fibrinogen, beta 2 microglobulin, erythrocyte sedimentation rate (ESR) and leukocytosis is observed. The increased levels of SAA in patients with FMF during the attack free period have been reported as a sign of subclinical inflammation. Also, studies have shown that during the attack the sensitivity of SAA and CRP was similar.
The aim of this study was to evaluate the sensitivity of SAA and other acute phase reactants in the diagnosis of FMF.
We reviewed the medical files of 100 patients with FMF followed up in our center in which SAA was measured; mutation analysis was performed and yet untreated. The diagnosis of FMF was established according to Livneh and Yalçınkaya criteria. Patients were divided according to the presence or absence of attack while the SAA measurement was performed. The level of white blood cells (WBC), ESR, CRP, fibrinogen and platelets that measured simultaneously with SAA were recorded. For each parameter the level above the normal range accepted as increased.
Sensitivity, specificity, positive and negative predictive values of acute phase reactans for predicting FMF attack
Table 1 Sensitivity, specificity, positive and negative predictive values of acute phase reactans for predicting FMF attack.
Decreased specificity and PPV of SAA in predicting FMF attack gave the impression that SAA levels during the attack free period in FMF patient is increased. In this respect it is concluded that SAA can be used as an independent laboratory parameter to support FMF diagnosis.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.